CMV Retinitis
What is CMV Retinitis?
CMV retinitis is a viral infection of the retina caused by cytomegalovirus. The retina is the light-sensitive tissue at the back of your eye that sends visual signals to your brain. This condition primarily affects people with severely weakened immune systems, such as those with advanced HIV or AIDS, organ transplant recipients, or people on immune-suppressing medications.
When your immune system is strong, cytomegalovirus typically remains dormant in your body without causing problems. Most healthy adults carry CMV without ever knowing it. However, when your immune system becomes compromised, the virus can reactivate and attack the retina. This leads to inflammation and damage that can cause vision loss or blindness if left untreated.
CMV retinitis was once very common in people with AIDS before effective HIV treatments became available. Today it is less common but still occurs in individuals with severely compromised immune function. Early detection and treatment are critical to preserving vision and preventing permanent eye damage.
Symptoms
- Blurred or cloudy vision that gets worse over time
- Floaters, small dark spots or squiggly lines in your vision
- Blind spots or dark areas in your visual field
- Light flashes or sudden changes in vision
- Loss of peripheral vision, seeing things only in the center
- Difficulty seeing objects on the side
- Progressive vision loss that may start in one eye
Many people experience no pain with CMV retinitis, which can delay diagnosis. The condition often starts in one eye but can spread to both eyes if not treated. Some people notice symptoms gradually over weeks, while others experience more rapid vision changes.
Concerned about CMV Retinitis? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
CMV retinitis develops when the cytomegalovirus reactivates in people with severely weakened immune systems. The virus is extremely common and spreads through bodily fluids like saliva, blood, urine, semen, and breast milk. Most people are infected with CMV at some point in life, but healthy immune systems keep the virus dormant. When your immune system becomes compromised, the virus can reactivate and spread to the eyes.
The main risk factor is having a CD4 count below 50 cells per microliter in people with HIV or AIDS. Other risk factors include receiving an organ transplant and taking anti-rejection medications, having certain cancers that weaken immunity, receiving chemotherapy, and taking high doses of corticosteroids or other immune-suppressing drugs. People born with immune deficiencies are also at higher risk for developing this condition.
How it's diagnosed
CMV retinitis is diagnosed through a comprehensive eye examination by an ophthalmologist, an eye specialist. Your doctor will dilate your pupils and examine your retina using specialized instruments. They look for characteristic signs of infection like white or yellow patches on the retina, retinal hemorrhages, and blood vessel inflammation. The appearance of these lesions often confirms the diagnosis in people with known immune suppression.
Blood tests can detect antibodies to cytomegalovirus, showing whether you have been exposed to the virus. Cytomegalovirus Antibody IgG indicates past or current infection, while IgM antibodies may suggest acute infection. However, these blood tests alone cannot diagnose CMV retinitis, which requires direct examination of the eye. Talk to your doctor about specialized testing and evaluation if you have risk factors for this condition.
Treatment options
- Antiviral medications like ganciclovir, valganciclovir, foscarnet, or cidofovir to fight the virus
- Medications given by mouth, through an IV, or as injections directly into the eye
- Long-term maintenance therapy to prevent the infection from returning
- Treating the underlying immune deficiency with antiretroviral therapy for HIV
- Adjusting immunosuppressive medications when possible in transplant patients
- Regular eye exams to monitor for disease progression or recurrence
- Surgery to repair retinal detachment if it occurs
- Working with both an ophthalmologist and infectious disease specialist
Frequently asked questions
People with severely weakened immune systems face the highest risk. This includes individuals with HIV who have CD4 counts below 50, organ transplant recipients on anti-rejection drugs, and people receiving chemotherapy or high-dose steroids. Before modern HIV treatments, CMV retinitis was a leading cause of blindness in AIDS patients.
Yes, CMV retinitis can lead to permanent vision loss or blindness if left untreated. The virus destroys retinal tissue, which cannot regenerate once damaged. Early diagnosis and treatment are essential to preserve remaining vision. Even with treatment, some vision loss may be permanent depending on how much damage occurred before starting therapy.
The progression rate varies but can be rapid in severely immunocompromised individuals. Without treatment, the infection can spread across the retina within weeks to months. Some people experience gradual vision changes over several weeks, while others notice more sudden deterioration. This is why regular eye exams are critical for people with weakened immune systems.
Cytomegalovirus antibody tests measure IgG and IgM antibodies in your blood. IgG antibodies indicate past or ongoing infection with CMV. IgM antibodies suggest a recent or acute infection. However, these tests show exposure to the virus but cannot diagnose CMV retinitis, which requires examination of the eye by a specialist.
Prevention focuses on maintaining immune function and monitoring high-risk individuals. People with HIV should take antiretroviral therapy to keep CD4 counts above 50. Some patients may receive preventive antiviral medications if their immune system is very weak. Regular eye exams allow for early detection before significant vision loss occurs.
The cytomegalovirus itself can spread through bodily fluids like saliva, blood, and sexual contact. However, CMV retinitis as a condition is not directly contagious from person to person. Most people already carry dormant CMV in their bodies. The eye infection only develops when the immune system becomes severely compromised.
Treatment involves antiviral medications that target cytomegalovirus. These include ganciclovir, valganciclovir, foscarnet, and cidofovir given orally, intravenously, or injected into the eye. Most patients need long-term maintenance therapy to prevent recurrence. Treating the underlying immune deficiency, such as with HIV medications, is equally important for controlling the infection.
Treatment can stop the infection from progressing and preserve remaining vision. However, retinal tissue that has already been destroyed cannot be restored. Early treatment before extensive damage occurs offers the best chance of maintaining functional vision. Some patients regain slight improvement as inflammation decreases, but significant vision loss is often permanent.
People with CD4 counts below 50 should have dilated eye exams every three months. Those with CD4 counts between 50 and 100 may need exams every three to six months. Your doctor will determine the right schedule based on your immune status and other risk factors. Regular monitoring allows for early detection when treatment is most effective.
CMV retinitis often starts in one eye but can spread to the other eye without treatment. About 50 percent of cases eventually involve both eyes if the infection is not controlled. The second eye may become affected weeks to months after the first. This is another reason why prompt treatment and ongoing monitoring are so important.